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httpCarotid artery stenting has increased risk of external
carotid artery occlusion compared with carotid
endarterectomy
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Objective: The external carotid artery (ECA) can be an important source of cerebral blood ﬂow in cases of high-grade internal
carotid artery stenosis or occlusion.However, the treatmentof theECA is fundamentally different between carotid endarterectomy
(CEA) and carotid artery stenting (CAS). CEA is routinely associated with endarterectomy of the ECA, whereas CAS excludes
the ECA from direct ﬂow. We hypothesize that these differences make ECA occlusion more common after CAS. Further, the
impact of CAS on blood ﬂow into the ECA is interesting because the ﬂow from the stent into the ECA is altered in a way thatmay
promote local inﬂammation andmay inﬂuence in-stent restenosis (ISR). Thus, our objective was to use our institutional database
to identify whether CAS increased the rate of ECA occlusion and, if it did, whether ECA occlusion was associated with ISR.
Methods: Patients undergoing CAS or CEA from February 2007 to February 2012 were identiﬁed from our institutional
carotid therapy database. Preoperative and postoperative images of patients who followed up in our institution were
included in the analysis of ECA occlusion and rates of ISR.
Results: There were 210 (67%) CAS patients and 207 (60%) CEA patients included in this analysis. Despite CAS patients
being younger (68 vs 70 years), having shorter follow-up (12.5 vs 56.2 months), and being more likely to take clopidogrel
(97% vs 35%), they had an increased rate of ECA occlusion (3.8%) compared with CEA patients (0.4%). CAS patients who
went on to ECA occlusion had an increased incidence of prior neck irradiation (50% vs 15%; P [ .03), but we did not
identify an association of ECA occlusion with ISR >50%.
Conclusions: Whereas prior publications have identiﬁed increased rates of external carotid stenosis, this is the ﬁrst
demonstration of increased ECA occlusion after CAS. However, ECA occlusion is uncommon (w4%) and did not have an
association with ISR >50%. Future work modeling ECA ﬂow patterns before and after CAS will be used to further test
this interaction. (J Vasc Surg 2015;61:119-25.)Stroke is a major cause of morbidity and mortality and manipulation of the plaque, whereas CAS routinely uses a
is the fourth leading cause of death in the United States.1
Trials such as the North American Symptomatic Carotid
Endarterectomy Trial and the European Carotid Surgery
Trial have deﬁnitively established carotid endarterectomy
(CEA) to be the “gold standard” therapy for high-grade
symptomatic carotid artery stenosis.2,3 Carotid artery stent-
ing (CAS) is an alternative method of treating carotid ar-
tery stenosis that has a role in certain clinical scenarios.4,5
CEA and CAS use very different methods to relieve carotid
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://dx.doi.org/10.1016/j.jvs.2014.06.008distal protection device that must cross the lesion before
placement. This may in part explain the increased stroke
rate with CAS.6 Still, CAS is relatively favored in certain sit-
uations, such as restenosis after prior CEA, after neck irra-
diation, or with anatomically prohibitive lesions.7-9
In addition to the different risks and beneﬁts associated
with CAS and CEA, CAS and CEA have fundamentally
different approaches to the external carotid artery (ECA).
CEA routinely treats stenotic ECAs as part of the endarter-
ectomy, whereas CAS intentionally covers the ECA. The
ECA primarily functions as a muscular artery to the face
and scalp, but it can be a source of collateral blood ﬂow
in the presence of high-grade internal carotid artery steno-
sis or occlusion.10-12 This exclusion of the ECA after CAS
leads to aberrant ﬂow patterns out of the stent struts into
the ECA. Thus, we hypothesize that these differences
would increase the risk of ECA occlusion after CAS
compared with CEA. Because altered ﬂow patterns can in-
crease the inﬂammatory proﬁle of endothelial cells,13 we
further hypothesized that ECA occlusion may coincide
with an increased rate of in-stent restenosis (ISR).
METHODS
Medical records from patients undergoing CAS and
CEA from February 2007 to March 2012 were used to119
Fig 1. Overview of data analysis. Flow diagram showing cohort selection algorithm and exclusion criteria.
CAS, Carotid artery stenting; CEA, carotid endarterectomy; ECA, external carotid artery; N, number of procedures.
*P < .05.
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examinations in our division’s vascular laboratory. After
identiﬁcation of patients, their records were retrospectively
evaluated from a single institution’s database under an
approved Institutional Review Board protocol, which
waived the need for patient consent.
Patient demographics, comorbidities, antiplatelet
regimen, imaging results, and clinical outcomes were
collected and analyzed. The degree of preoperative ECA ste-
nosis was assessed by duplex velocities, angiography, or axial
imaging before the procedure, and both symptomatic and
asymptomatic patientswere included in the study. Indications
to undergo stenting included medical comorbidities, contra-
lateral occlusion, prior history of ipsilateral neck surgery
includingCEA, prior irradiation of the neck, and anatomically
challenging lesions. “Surgical high risk” for CEA included
congestive heart failure (class III/IV), severe chronic obstruc-
tive pulmonary disease, and severe coronary artery disease that
could not be revascularized. The decision to undergo CAS
vs CEA was made by the treating physicians and the patients.
Patients in both the CEA and CAS groups underwent
duplex imaging of their carotid arteries at 1 month,
6 months, and 1 year after their index operation and yearly
thereafter. Patients without follow-up imaging in our divi-
sion’s vascular laboratory were excluded from the analysis.
The most recent duplex imaging on follow-up was used to
determine patency of the ECA, and our vascular labora-
tory’s carotid duplex ultrasound criteria or axial imaging
(magnetic resonance angiography or computed tomogra-
phy angiography) was used to determine degree of ISR
in patients undergoing CAS. ISR >50% was deﬁned as
peak systolic velocity >175 cm/s, and ISR >70% was
deﬁned as peak systolic velocity >300 cm/s and end-
diastolic velocity >140 cm/s.14 For patients undergoing
reoperation on the same vessel, the last documented ultra-
sound study before reoperation was used. For patients un-
dergoing CAS, intraoperative angiography was used to
determine pre-stent ECA patency, and preoperative axial
imaging or duplex ultrasound was used to analyze thedegree of preoperative ECA stenosis. For those undergoing
CEA, operative reports and preoperative duplex ultrasound
were used to determine preoperative ECA patency, and
axial imaging or duplex ultrasound was used to analyze
the degree of preoperative ECA stenosis. Seven patients
in the CAS cohort and three patients in the CEA cohort
with ECA occlusion before the procedure were excluded
from the analysis.
The objective of this study was to compare the inci-
dence of ECA occlusion after CEA and CAS. Secondary
objectives included analyzing the impact of ECA occlusion
on ISR. ECA patency in patients undergoing CAS was
compared with that in patients undergoing CEA. The
CAS group was then subdivided into patients with ECA
occlusion and those without ECA occlusion to compare
rates of ISR between the two groups.
Categorical variables were compared by c2 or Fisher
exact test (dependent on sample size) to determine statisti-
cal signiﬁcance, and continuous variables were compared
by Student t-test. P < .05 was used as the threshold for sta-
tistical signiﬁcance.
RESULTS
Between February 2007 and March 2012, 312 CAS
(299 patients) and 344 CEA (335 patients) procedures
were performed at our institution. From this group of pa-
tients, 210 (67%) CAS patients had follow-up duplex imag-
ing available at the time of the analysis, and 207 (60%)
CEA patients had follow-up carotid duplex imaging in
our vascular laboratory (60%) (Fig 1). Patients were simi-
larly matched with the exception of variables known to
be associated with CAS (younger, symptomatic, cervical
irradiation, prior CEA). In addition, the CAS cohort had
a shorter follow-up and increased use of clopidogrel
(Table I).
There was a signiﬁcantly increased rate of ECA occlu-
sion in the CAS group compared with the CEA group
(CAS, eight arteries [3.8%]; CEA, one artery [0.4%];
P ¼ .04). All other postoperative outcomes were similar
Table I. Baseline demographics of carotid artery stenting (CAS) and carotid endarterectomy (CEA) treatment groups
Variable
CAS (n ¼ 312) CEA (n ¼ 344)
P valuec, CAS vs CEA
CAS,
No. (%)
CAS no f/u,
No. (%) P valuea
CEA,
No. (%)
CEA no f/u,
No. (%) P valueb
Demographics
Patients 210 (67) 102 (33) 207(60) 137 (40)
Age, years 68 68 1 70 67 0.001e .03e
Follow-up, months 12.5 NA NA 56.2 NA NA <.001e
Gender, male 134 (64) 51 (53) .03e 127 (61) 81 (60) 7 .3
Symptomatic 91 (43) 46 (52) .8 77 (37) 66 (48) .05e .2
Comorbidities
Smoking 67 (32) 38 (37) .4 67(32) 36 (26) .2 .8
Diabetes 74 (36) 35 (34) .9 69 (33) 48 (35) .8 .7
HTN 188 (89) 93 (91) .7 192 (93) 122 (89) .2 .2
HLD 153 (72) 78 (77) .6 160 (77) 106 (77) 1 .3
CKD 20 (10) 9 (9) 1 25 (12) 14 (10) .9 .4
Cervical irradiation 31 (15) 8 (8) .1 4 (2) 1 (1) .6 <.001e
Prior CEA 55 (26) 25 (25) .8 16 (8) 12 (9) .8 <.001e
Antiplatelet regimen
ASA 175 (84) 83 (85)d .7 184 (89) 116 (87)d .6 .2
Clopidogrel 197 (94) 89 (92)d .6 73 (35) 41 (31)d .4 <.001e
ASA, Aspirin; CKD, chronic kidney disease; f/u, follow-up; HLD, hyperlipidemia; HTN, hypertension; NA, not applicable.
Baseline demographics of patients who underwent CAS and CEA (comparison in far right column). CEA patients were older, had longer follow-up, were less
likely to have had irradiation or prior CEA, and were less likely to be taking clopidogrel. CAS and CEA patients were then segregated by those who followed
up and those who did not. For CAS, there were more male patients in the follow-up group. For CEA, the follow-up patients were older and less likely to be
symptomatic than those who did not follow up.
aP value of CAS compared with CAS without follow-up.
bP value of CEA compared with CEA without follow-up.
cP value of CAS compared with CEA.
dDischarge medications percentage and P value calculated excluding in-hospital deaths (CAS, n ¼ 5; CEA, n ¼ 3).
eStatistically signiﬁcant.
Table II. Clinical outcomes of patients undergoing carotid artery stenting (CAS) compared with carotid endarterectomy
(CEA)
Variable
CAS,
No. (%)
CAS no f/u,
No. (%) P valuea
CEA,
No. (%)
CEA no f/u,
No. (%) P valueb P valuec, CAS vs CEA
Patients 210 102 207 137
ECA occlusion 8 (4) NA NA 1 (0.4) NA NA .04d
30-day stroke/death/MI 8 (4) NA NA 4 (2) NA NA .4
CVA 5 (2) 4 (4) .5 3 (1.4) 5 (4) .3 1
TIA 2 (0.9) 0 (0) .6 2 (0.9) 1 (1) 1 1
Death 5 (2) 0 (0) .2 3 (1) 0 (0) .3 .7
MI 0 (0) 1 (1) .3 0 (0) 2 (1) 1 1
Bradycardia/hypotension 10 (4.7) 10 (10) .1 5 (2.4) 2 (2) 1 .3
Hyperperfusion syndrome 2 (0.9) 0 (0) .6 2 (0.9) 1 (1) 1 1
Wound site hematoma 2 (0.9) 2 (2) .6 1 (0.4) 3 (2) .3 1
CVA, Cerebrovascular accident; ECA, external carotid artery; f/u, follow-up; MI, myocardial infarction; NA, not applicable; TIA, transient ischemic attack.
Clinical outcomes comparing CAS with CEA and differences between those who followed up in our vascular laboratory and those who did not among CAS
and CEA patients. There were no differences within the groups, but ECA occlusion was signiﬁcantly more common in the CAS group.
aP value for CAS compared with CAS without follow-up.
bP value for CEA compared with CEA without follow-up.
cP value for CAS compared with CEA.
dIndicates clinical signiﬁcance.
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velocities in the ECA were higher in the CAS-treated
patients compared with the CEA patients. However,
within the CAS group, the preoperative ECA peak systolic
velocities were similar between the patients who devel-
oped ECA occlusion and those who did not, but theend-diastolic velocity was higher in the ECA occlusion
group (44 cm/s compared with 31 cm/s; P < .001)
(Table III). There was also an increased frequency of
neck irradiation within the CAS patients who developed
ECA occlusion but not with other indications for CAS
(Table IV).
Table III. Average preoperative external carotid artery
(ECA) velocities
Variable
ECA occlusion,
average velocity
No ECA occlusion,
average velocity P value
CAS group
PSV 201 cm/s 203 cm/s 1
EDV 44 cm/s 31 cm/s <.001a
CEA group
PSV 246 cm/s 150 cm/s NAb
EDV 48 cm/s 23 cm/s NAb
CAS, Carotid artery stenting; CEA, carotid endarterectomy; EDV, end-
diastolic velocity; PSV, peak systolic velocity.
Preoperative PSV among those in the CAS group was not statistically
different among those with and without ECA occlusion, but preoperative
EDV was signiﬁcantly higher among CAS patients who went on to ECA
occlusion. The statistical difference could not be calculated among the CEA
group because there was only one occluded ECA in the occlusion group.
aIndicates clinical signiﬁcance.
bOnly one value for velocity in CEA group with ECA occlusion; therefore,
Student t-test and P value could not be calculated.
Table IV. Indications for stenting in carotid artery
stenting (CAS) group
Variable
ECA occlusion,
No. (%)
No ECA
occlusion, No. (%) P value
Patients 8 196
Cervical irradiation 4 (50) 30 (15) .03a
Prior CEA 1 (13) 56 (27) .44
Prohibitive anatomy 2 (25) 34 (17) .63
Medical comorbidities 1 (13) 3 (0.2) .15
CEA, Carotid endarterectomy; ECA, external carotid artery.
Prior cervical irradiation was more common in the CAS patients who went
on to ECA occlusion than in those who did not. There were no other in-
teractions between indications for CAS and ECA occlusion.
aIndicates clinical signiﬁcance.
Table V. In-stent restenosis (ISR) among carotid artery
stenting (CAS) patients with and without external carotid
artery (ECA) occlusion
Variable
ECA occlusion,
No. (%)
No ECA
occlusion, No. (%) P value
Patients 8 (3.8) 193 (96.2)
ISR >50% 2 (25) 27 (14) .6
ISR >50-69% 2 (25) 18 (9) .2
ISR >70% 0 (0) 8 (4) 1
Stent occlusion 0 (0) 1 (0.5) 1
ISR >70%: axial imaging or peak systolic velocity >175 cm/s and
end-diastolic velocity >140 cm/s. ISR 60-69%: peak systolic velocity
>175 cm/s.
There was no interaction identiﬁed between ECA occlusion and ISR or CAS
occlusion.
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with an increased rate of ISR >50% (Table V), but patients
undergoing CAS with subsequent ECA occlusions were
more likely to have had cervical irradiation compared
with those undergoing CAS without ECA occlusions
(four [50%] vs 30 [15%]; P ¼ .03). No ISR in patients
with ECA occlusions required repeated intervention, and
no ECA occlusions resulted in symptoms. Five patients un-
derwent reoperation on the same artery in the CAS group
and ﬁve underwent reoperation in the CEA group in this
time period.
DISCUSSION
The ECA is an interesting artery in that it is part of the
robust collateral system in the neck, but it rarely causes
symptoms until it is occluded. Even with ECA ligation,
symptoms are rare. However, in the setting of high-grade
internal carotid artery stenosis or occlusion, the ECA
can contribute meaningfully to the cerebral blood ﬂow
in up to 80% of these patients.14 Also, isolated ECAendarterectomy in patients with internal carotid artery oc-
clusion is well established in the literature.15,16 Thus, the
ECA can be an important part of cerebral perfusion in these
patients. Because CAS is commonly performed in patients
with higher anatomic risk, including contralateral occlusion
and prior CEA or neck irradiation, the ECA may be partic-
ularly important in this cohort of patients. Thus, our
objective in this study was to analyze our institution’s
high-volume carotid therapy results to determine if CAS
was associated with increased rates of ECA occlusion.
Whereas previous studies have shown an increased rate
of ECA stenosis with CAS,17-19 this is the ﬁrst study to ﬁnd
an increased rate of ECA occlusion. ECA exclusion as a
result of CAS has recently been demonstrated to alter the
arterial ﬂow patterns into the ECA, in part owing to
poor apposition of the stent to the ECA oriﬁce. These
altered ﬂow patterns alter wall shear stress, contributing
to proinﬂammatory and proatherosclerotic arterial wall
remodeling.13 We speculated that these effects not only
may inﬂuence ECA occlusion rates but also may play a
role in ISR, which is known to be a persistent and variable
problem with CAS [ISR rates of 3%-17%],20,21 but we did
not identify an association of ECA occlusion with ISR
>50%. This may be due in part to the low rate of ECA oc-
clusion (w4%) in the CAS group. Further, there are a num-
ber of other factors that contribute to ISR in addition to
changes in wall shear stress.22
Reichmann et al recently demonstrated, as others
have before, that CAS is associated with increased ECA
duplex velocities, but they did not identify increased
rates of ECA occlusion.17 Whereas their numbers were
substantially lower than ours, the lack of even a trend
(one post-CAS occlusion; two post-CEA occlusions) sug-
gests differences between our respective patient popula-
tions; but somewhat surprisingly, this increased rate of
irradiation did not correlate with increased rate of ISR.
Because neck irradiation was signiﬁcantly different for
CAS patients who went on to ECA occlusion compared
with those who did not, this is one important difference be-
tween our data and the data of Reichmann and de
Borst,17,18 in which the incidence of irradiation was not
Fig 2. Annual carotid therapy case volume. Procedure numbers
segregated as carotid artery stenting (CAS) and carotid endarter-
ectomy (CEA) per year during the course of the study. The year
2012 was not included as only January and February were included
in the study.
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vical irradiation of 101 CAS patients (and 165 CEAs).
They reported two occluded ECAs after CAS and none
in the CEA group. Unfortunately, this report did not
address whether the patients with occluded ECAs had irra-
diation.19 Whereas the preoperative ECA peak systolic ve-
locities were similar between CAS patients regardless of
whether ECA occlusion occurred, the end-diastolic veloc-
ity increased in those who went on to occlude. Here the
absolute difference was small (44 cm/s vs 31 cm/s), and
we are not sure what role a small increase in end-diastolic
velocity in the ECA had on our ﬁndings. In addition, the
patients seen in the northeastern part of the United States
and the Netherlands are likely to be very different from the
patients in the southeastern part of the United States. In
fact, our institution is in the very middle of the stroke
heat map for the United States.23 Although prospective
data collections from patients/practitioners of different re-
gions will likely bring much information to the local deliv-
ery of quality health care, the Society for Vascular Surgery’s
Vascular Quality Initiative data are most mature in the
Northeast. Thus, it is of limited value to our population
currently. However, we are members of the Georgia-
Florida Vascular Quality Initiative group, and future
analyses of these data, along with comparisons in other re-
gions, will be helpful in clarifying the differences that exist
and create the discrepancies in the literature.
Finally, this study does have signiﬁcant limitations that
need to be addressed. The data collected were analyzed in a
retrospective fashion. However, the data collected were
from a “real-world” experience and included all patients
seen in our institution, thus not biasing results toward
one specialty or another. In fact, the CAS group were
younger and had shorter length of follow-up but an
increased rate of clopidogrel use. Logically, these differ-
ences should prejudice the results in favor of CAS and
the potential of a type II statistical error. Given our ﬁnding
of increased ECA occlusion rates after CAS, we believe
longer and more complete follow-up would only bias the
results in support of this ﬁnding. In contrast, we did not
identify an association of ECA occlusion with an increased
rate of ISR. This leaves open to debate whether altered
arterial ﬂow patterns and shear stress in the ECA contribute
to ISR. Ongoing work in our division is currently devel-
oping a modeling program and ex vivo culture model to
better characterize the impact of altered ﬂow patterns on
the ECA through the stent struts. Second, the percentage
of follow-up patients in this data set was 67% (CAS) and
60% (CEA). Some of this is explained by including only
duplex results from our division’s Intersocietal Accredita-
tion Commission vascular laboratory and that ECA veloc-
ities were not routinely documented before our transition
to an electronic storage system in 2010. Our institution
is a quaternary referral center with many of our patients
being referred for therapy by vascular surgeons and inter-
ventionalists from the surrounding area. This leads to
follow-up regimens that include outside physicians and
various vascular laboratories. To secure the most reliableinformation, we chose to restrict the duplex follow-up
studies to our laboratory. Further, the demographics of
the patients in the CAS and CEA groups were separately
reported between those with and without follow-up.
Here we found small differences between those who fol-
lowed up and those who did not. In the CAS group, there
were fewer male patients in the lost to follow-up group.
For CEA, the lost to follow-up patients were younger
and more likely to be symptomatic. There were no other
signiﬁcant differences between those patients who followed
up and those who did not (Table I). Further, our referral
pattern has also led our institution to have a dispropor-
tionate number of CAS procedures, but the number of
CEA and CAS procedures was stable during the years inter-
rogated in this manuscript (Fig 2).
CONCLUSIONS
CAS is associated with increased rates of ECA occlu-
sion over CEA, and patients with ECA occlusion after
CAS had an increased incidence of neck irradiation
compared with CAS patients who had patent ECAs.
Ongoing work in our laboratory modeling altered ﬂow
through the stent into the ECA by use of clinical imaging
and ex vivo arterial culture will help better understand the
biology of this phenomenon. Finally, the impact of arterial
ﬂow through stent struts on the arterial wall biology is
important to all vascular trees and not limited only to
ECA occlusion. We hope this work will help spur further
investigation of this ﬁnding.
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leagues have presented a retrospective observational study about
the frequency of external carotid artery (ECA) occlusion after ca-
rotid interventions performed at their institution. The remarkable
excellent outcomes obtained with both carotid artery stenting
(CAS) and carotid endarterectomy (CEA) at the authors’ institu-
tion indicate that both carotid interventions are safe and effective
when these are applied to the appropriate patients. As shown in
this study, ECA occlusion is more frequent after CAS than after
CEA. The authors also found an increased frequency of in-stent
restenosis with ECA occlusion among patients undergoing CAS.
Of note, the instances of ECA occlusion occurred primarily among
patients with a history of irradiation or previous CEA. On the basis
of the results of the current study, I have the following comments
and questions:
1. What was the status of the ECA before the carotid interven-
tion? You did exclude the patient with preoperative ECA oc-
clusion but did include those with stenosis. Is there anassociation between the degree of preprocedural ECA stenosis
and later occlusion?
2. You have found an association between the frequency of ECA
occlusion and CAS and also between ECA occlusion and in-
stent restenosis after CAS. In your presentation and manu-
script, you try to establish a cause-effect relationship for these
ﬁndings, which I believe does not exist. In your series, ECA
occlusions and in-stent restenosis occurred primarily in pa-
tients who a history of prior irradiation or CEA, which sug-
gests that prior irradiation and CEA are the culprits for ECA
occlusion and in-stent restenosis. Indeed, prior neck irradia-
tion and CEA are the main risk factors for restenosis after all
carotid interventions. In this regard, do you believe it is neces-
sary to treat patients with asymptomatic carotid stenosis with a
history of prior irradiation or CEA?
3. In your series, all instances of ECA occlusion and in-stent
restenosis were asymptomatic. What is then the clinical signif-
icance, if any, of your ﬁndings, and how has your practice
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indications for CAS and CEA may indeed be the same irre-
spective of the risk of future ECA occlusion. Avoiding CAS
among asymptomatic patients with prior irradiation or CEA,
who should actually best be managed with medical therapy,
may be the only alternative to reduce the incidence of postpro-
cedural ECA occlusion.
I want to thank the authors for sending me their manuscript in
advance and the Association for the honor of discussing this impor-
tant study and the privilege of the ﬂoor.
Dr Kevin Brown. To address the state of the ECA before
intervention, we do have some data on the state of the patients
before their interventions. I do not have exact numbers on the ve-
locities of those ECAs, but certainly the majority of the ECAs were
patent before their procedures on the basis of duplex ultrasound as
well as axial imaging, and we are going to further investigate these
patients as to the degree of stenosis before their procedure. As far
as whether it is necessary to treat these patients who have had irra-
diation, especially asymptomatic patients, I think that we alwayshave to weigh the risks and beneﬁts of every individual patient
and decide whether, on an individual basis, treatment is warranted.
Often, this is a difﬁcult decision, especially when it comes to pa-
tients with hostile necks, such as prior irradiation and prior surgical
procedures. Given our ﬁndings, ECA occlusions may be indicative
of a more aggressive disease pattern because of irradiation, and it
does give us pause to treat some of these patients who are asymp-
tomatic. Last, with regard to how this changes our treatment man-
agement, I do not know that it changes our treatment and
approach to these patients preoperatively, but I do think that there
is some evidence here that there is a more progressive and aggres-
sive disease pattern occurring. Whether this is due to changes in
hemodynamics and shear forces or is secondary to cervical irradia-
tion, a more aggressive process is not clear from this report, but it
is an area that we are actively investigating at our institution. I do
think that using the ECA occlusion as more of a marker of progres-
sive and aggressive disease may warrant closer inspection and
follow-up with more frequent duplex imaging, which does change
how I would approach these patients.
